Cost-effective shallow genome-wide sequencing for profiling plasma cfDNA signatures to enhance lung cancer detection

This assay provides a cost-effective, accurate, and minimally invasive method for LC detection, addressing the limitations of current screening methods. It represents a promising complementary tool to improve early detection and patient outcomes in LC.